Artigos com autorizações de acesso público - Erik A. Williams, M.D.Saiba mais
1 artigo não disponível publicamente
Clear cell mesotheliomas with inactivating VHL mutations and near‐haploid genomic features
M Michal, O Kravtsov, JS Ross, D Skanderová, P Martínek, E Mosaieby, ...
Genes, Chromosomes and Cancer 62 (5), 267-274, 2023
Autorizações: US National Institutes of Health
16 artigos disponíveis publicamente
Reliability and convergent validity of two outcome instruments for pemphigus
M Rosenbach, DF Murrell, JC Bystryn, S Dulay, S Dick, S Fakharzadeh, ...
Journal of investigative dermatology 129 (10), 2404-2410, 2009
Autorizações: US National Institutes of Health
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
TA Juratli, C Thiede, MVA Koerner, SS Tummala, D Daubner, ...
Oncotarget 8 (65), 109228, 2017
Autorizações: US National Institutes of Health
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome
TA Juratli, D McCabe, N Nayyar, EA Williams, IM Silverman, SS Tummala, ...
Acta neuropathologica 136, 779-792, 2018
Autorizações: US National Institutes of Health, German Research Foundation, Damon Runyon …
Absence of Alzheimer disease neuropathologic changes in eyes of subjects with Alzheimer disease
EA Williams, D McGuone, MP Frosch, BT Hyman, N Laver, ...
Journal of Neuropatholgy & Experimental Neurology 76 (5), 376-383, 2017
Autorizações: US National Institutes of Health
Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53
L Zhao, W Li, C Marshall, T Griffin, M Hanson, R Hick, T Dentchev, ...
Cancer research 69 (24), 9439-9447, 2009
Autorizações: US National Institutes of Health
Accelerated progression of IDH mutant glioma after first recurrence
JJ Miller, F Loebel, TA Juratli, SS Tummala, EA Williams, TT Batchelor, ...
Neuro-oncology 21 (5), 669-677, 2019
Autorizações: US National Institutes of Health
Genotype-targeted local therapy of glioma
GM Shankar, AR Kirtane, JJ Miller, H Mazdiyasni, J Rogner, T Tai, ...
Proceedings of the National Academy of Sciences 115 (36), E8388-E8394, 2018
Autorizações: US National Institutes of Health, Wellcome Trust, American Brain Tumor …
PI3K/AKT/mTOR pathway alterations promote malignant progression and xenograft formation in oligodendroglial tumors
K Tateishi, T Nakamura, TA Juratli, EA Williams, Y Matsushita, S Miyake, ...
Clinical Cancer Research 25 (14), 4375-4387, 2019
Autorizações: US National Institutes of Health
Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss
DM Marchione, A Lisby, AN Viaene, M Santi, ML Nasrallah, LP Wang, ...
Modern Pathology 32 (10), 1434-1446, 2019
Autorizações: US National Institutes of Health
Pan-Cancer Landscape Analysis Reveals Recurrent KMT2A-MAML2 Gene Fusion in Aggressive Histologic Subtypes of Thymoma
LR Massoth, YP Hung, D Dias-Santagata, M Onozato, N Shah, ...
JCO precision oncology 4, 109-115, 2020
Autorizações: US National Institutes of Health
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1
CHG Lucas, EA Sloan, R Gupta, J Wu, D Pratt, HN Vasudevan, ...
Acta neuropathologica 144 (4), 747-765, 2022
Autorizações: US National Institutes of Health
TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations
EA Williams, JJ Miller, SS Tummala, T Penson, AJ Iafrate, TA Juratli, ...
Acta neuropathologica communications 6, 1-6, 2018
Autorizações: US National Institutes of Health, German Research Foundation
Biomarkers in breast cancer: An integrated analysis of comprehensive genomic profiling and Pd‐L1 immunohistochemistry biomarkers in 312 patients with breast cancer
RSP Huang, X Li, J Haberberger, E Sokol, E Severson, DL Duncan, ...
The oncologist 25 (11), 943-953, 2020
Autorizações: US National Institutes of Health
A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4
EA Williams, PK Brastianos, H Wakimoto, A Zolal, MG Filbin, DP Cahill, ...
Acta neuropathologica 146 (3), 515-525, 2023
Autorizações: US Department of Defense, US National Institutes of Health
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs
EA Williams, A Ravindranathan, R Gupta, NO Stevers, AK Suwala, ...
Neuro-oncology 25 (12), 2221-2236, 2023
Autorizações: US National Institutes of Health
Quasimesenchymal phenotype predicts systemic metastasis in pancreatic ductal adenocarcinoma
KK Mahadevan, KS Arora, A Amzallag, E Williams, AS Kulkarni, ...
Modern Pathology 32 (6), 844-854, 2019
Autorizações: US National Science Foundation, US National Institutes of Health
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador